NEW YORK, January 9, 2017 – Progyny, a leading reproductive health technology and services company, today announced the appointment of former WebMD CFO, Peter Anevski, as its Chief Financial Officer and Chief Operating Officer. He joins newly appointed Chief Executive Officer, David Schlanger, and President of Health Services, Karin Ajmani, on Progyny’s management team.
“I’m delighted to become a part of Progyny and resume my longstanding working relationship with CEO, David Schlanger. It’s an exciting time to be at the company as it charts the next phase of growth in developing unique science-based and data-driven reproductive technology and in penetrating the employer market for fertility benefits,” said Anevski.
Commenting on Anevski’s appointment, Schlanger commented: “Pete brings over 17 years of experience in the healthcare industry at WebMD where he and I worked together to deliver record revenues and profits and substantial share price appreciation during the more than three years that we led the company. Progyny is now in a position where it needs the financial and operations skills of someone like Pete. He will be a critical member of the management team that will take Progyny forward to capitalize on the significant opportunity in the global fertility services market.”
About Peter Anevski
Pete joined WebMD in 1999 and served as senior management in a number of finance and operations roles, becoming the company’s CFO in 2013. He played an integral role in WebMD’s growth in revenue and profitability through implementation of changes in pricing and market positioning, programmatic strategy and execution and other finance and operating disciplines that led to the company’s improved financial performance. Prior to joining WebMD, Pete was in corporate accounting at Toys “R” Us and a CPA with Wiss &Co, LLP.
Progyny is a leading fertility benefits company that combines service, science, technology and data to provide comprehensive value based fertility solutions for self-insured employers. Progyny’s benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco, CA. Please visit www.progyny.com.